| Issue |
Section |
Title |
File |
| Vol 79, No 9 (2004) |
Editorial article |
Effects of carvedilol, atenolol and their combination with fosinopril on cardiac rhythm variability, clinicofunctional status and quality of life in patients with postinfarction left ventricular dysfunction |
|
| Vol 80, No 12 (2008) |
Editorial article |
Clinico-immunological disorders in patients with ischemic heart disease and metabolic syndrome: correction with nebivolol |
|
| Vol 81, No 2 (2009) |
Editorial article |
Combined antihypertensive treatment in hypertensive patients and type 2 diabetes mellitus |
|
| Vol 81, No 3 (2009) |
Editorial article |
Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus |
|
| Vol 81, No 5 (2009) |
Editorial article |
Long-term results of coronary endovascular revascularisation with eluting sirolimus-stents in patients with coronary heart disease comorbid with type-2 diabetes mellitus: evidence from 18-month prospective study |
|
| Vol 84, No 12 (2012) |
Editorial article |
Quality of life in patients with coronary heart disease associated with metabolic syndrome: Results of factor analysis |
|
| Vol 85, No 1 (2013) |
Editorial article |
Impact of angiotensionogen and angiotensin II receptor type 1 gene polymorphisms on the development and course of chronic heart failure |
|
| Vol 85, No 5 (2013) |
Editorial article |
Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome |
|
| Vol 87, No 4 (2015) |
Editorial article |
Assessment of the role of matrix metalloproteinase-2 gene polymorphism in the development of chronic heart failure |
|
| Vol 88, No 9 (2016) |
Editorial article |
Role of soluble Fas ligand in myocardial remodeling, severity and outcomes of chronic heart failure |
(Rus)
|
